S100 proteins in IgA vasculitis and other systemic vasculitides – from pathogenic mechanisms to clinical biomarkers: a systematic review

Key Takeaways for GI Nurses

• S100 proteins may serve as valuable biomarkers for identifying and monitoring IgA vasculitis, particularly when patients present with gastrointestinal manifestations requiring endoscopic evaluation
• Understanding S100 protein involvement in systemic vasculitides can enhance your ability to recognize early inflammatory markers during patient assessment and pre-procedure screening
• This research contributes to the growing body of evidence supporting biomarker-driven approaches to vasculitis diagnosis, which may influence future protocols for GI bleeding workups in pediatric and adult patients
• Knowledge of S100 proteins as potential diagnostic tools may help nurses better communicate with gastroenterologists about patients presenting with unexplained GI symptoms and possible underlying vasculitic conditions

Clinical Relevance

For endoscopy and GI nursing professionals, this systematic review on S100 proteins holds significant implications for patient care, particularly when managing cases involving suspected or confirmed vasculitis. IgA vasculitis, formerly known as Henoch-Schönlein purpura, frequently presents with gastrointestinal manifestations including abdominal pain, GI bleeding, and intestinal complications that may require endoscopic intervention. Understanding the role of S100 proteins as both pathogenic mediators and potential biomarkers can enhance nursing assessment skills and improve recognition of patients who may benefit from earlier diagnostic workup.

From a practical standpoint, this research may influence future nursing protocols in several ways. As biomarker testing becomes more integrated into clinical practice, GI nurses may need to incorporate S100 protein level monitoring into their patient assessment repertoire, similar to how inflammatory markers like CRP or ESR are currently utilized. This could be particularly relevant during pre-procedure evaluations, where nurses often serve as the first point of contact for identifying patients with complex underlying conditions. Additionally, understanding these biomarkers may help nurses provide more informed patient education about the connection between systemic inflammatory conditions and GI symptoms.

The systematic review format of this research also underscores the importance of evidence-based practice in nursing. As S100 proteins potentially transition from research targets to clinical biomarkers, endoscopy nurses will need to stay current with evolving diagnostic approaches and may need to adapt documentation practices, patient monitoring protocols, and interdisciplinary communication strategies to incorporate these new tools effectively into routine care.

Bottom Line

This systematic review highlights S100 proteins as promising biomarkers for IgA vasculitis and other systemic vasculitides, which is clinically significant for GI nurses because these conditions frequently present with gastrointestinal manifestations requiring endoscopic evaluation. While this research is still in the investigational phase, understanding the potential role of S100 proteins in vasculitis diagnosis and monitoring may help endoscopy nurses better recognize inflammatory patterns in patients presenting with unexplained GI symptoms, ultimately supporting earlier identification and more targeted care for patients with these complex systemic conditions.